These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1203 related items for PubMed ID: 8957075

  • 1. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD, Bar-Eli M.
    Oncogene; 1996 Dec 05; 13(11):2339-47. PubMed ID: 8957075
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of melanoma metastasis.
    Bar-Eli M.
    J Cell Physiol; 1997 Nov 05; 173(2):275-8. PubMed ID: 9365536
    [Abstract] [Full Text] [Related]

  • 3. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
    Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M.
    EMBO J; 1998 Aug 03; 17(15):4358-69. PubMed ID: 9687504
    [Abstract] [Full Text] [Related]

  • 4. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
    Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ.
    Cancer Res; 1995 Jun 01; 55(11):2470-5. PubMed ID: 7758001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 01; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ.
    Arterioscler Thromb Vasc Biol; 2007 Mar 01; 27(3):540-7. PubMed ID: 17204664
    [Abstract] [Full Text] [Related]

  • 9. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
    Zakut R, Perlis R, Eliyahu S, Yarden Y, Givol D, Lyman SD, Halaban R.
    Oncogene; 1993 Aug 01; 8(8):2221-9. PubMed ID: 7687762
    [Abstract] [Full Text] [Related]

  • 10. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C, Khan WB, Leigh BR, Turner AM, Wilder RB, Knox SJ.
    Cancer Res; 1995 Aug 01; 55(15):3431-7. PubMed ID: 7542170
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr 01; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 12. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT, van Belle P, Elenitsas R, Elder DE.
    Mod Pathol; 1997 Sep 01; 10(9):939-44. PubMed ID: 9310959
    [Abstract] [Full Text] [Related]

  • 13. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
    Timeus F, Crescenzio N, Valle P, Pistamiglio P, Piglione M, Garelli E, Ricotti E, Rocchi P, Strippoli P, Cordero di Montezemolo L, Madon E, Ramenghi U, Basso G.
    Exp Hematol; 1997 Nov 01; 25(12):1253-60. PubMed ID: 9357969
    [Abstract] [Full Text] [Related]

  • 14. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 15. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
    Welker P, Schadendorf D, Artuc M, Grabbe J, Henz BM.
    Br J Cancer; 2000 Apr 07; 82(8):1453-8. PubMed ID: 10780526
    [Abstract] [Full Text] [Related]

  • 16. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
    Giehl KA, Nägele U, Volkenandt M, Berking C.
    J Cutan Pathol; 2007 Jan 07; 34(1):7-14. PubMed ID: 17214848
    [Abstract] [Full Text] [Related]

  • 17. Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7.
    Nishida K, Tsukamoto T, Uchida K, Takahashi T, Takahashi T, Ueda R.
    Anticancer Res; 1996 Jan 07; 16(6B):3397-402. PubMed ID: 9042197
    [Abstract] [Full Text] [Related]

  • 18. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
    Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M.
    Cancer Res; 1997 Jun 01; 57(11):2295-303. PubMed ID: 9187135
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
    Hofmann UB, Kauczok-Vetter CS, Houben R, Becker JC.
    Clin Cancer Res; 2009 Jan 01; 15(1):324-9. PubMed ID: 19118061
    [Abstract] [Full Text] [Related]

  • 20. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M.
    Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.